Company: PTPI
Filing Date: 2025-02-10
Form Type: S-1/A
Source: 0001410578-25-000108
Chunk: 21

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-10
Form: S-1/A
Chunk 21
---
 our common stock is being sold together with a Series A Warrant to purchase one share of our common stock. Each Series A Warrant will have an exercise price of $        per share, will be exercisable at any time beginning on the first trading day following the date of Warrant Stockholder Approval and will expire on the five year anniversary of the Initial Exercise Date.The shares of common stock and Pre-Funded Warrants, and the accompanying Series Warrants, as the case may be, can only be purchased together in this offering but will be issued separately.This prospectus also relates to the offering of the shares of common stock issuable upon exercise of the Series A Warrants. Because we will issue a Series A Warrant for each share of common stock and for each Pre-Funded Warrant sold in this offering, the number of Series A Warrants sold in this offering will not change as a result of a change in the mix of the shares of our common stock and Pre-Funded Warrants sold.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

9

| Series B Warrants | ​ | Each share of our common stock and each Pre-Funded Warrant to purchase one share of our common stock is being sold together with a Series B Warrant to purchase one share of our common stock. Each Series B Warrant will have an exercise price of $     per share, will be exercisable at any time beginning on the first trading day following the date of Warrant Stockholder Approval and will expire on the one (1) year anniversary of the Initial Exercise Date.The shares of common stock and Pre-Funded Warrants, and the accompanying Series Warrants, as the case may be, can only be purchased together in this offering but will be issued separately.This prospectus also relates to the offering of the shares of common stock issuable upon exercise of the Series B Warrants. Because we will issue a Series B Warrant for each share of common stock and for each Pre-Funded Warrant sold in this offering, the number of Series B Warrants sold in this offering will not change as a result of a change in the mix of the shares of our common stock and Pre-Funded Warrants sold.Holders the Series B Warrants may effect an “alternative cashless exercise” at any time while the Series B Warrants are outstanding following the Initial Exercise Date. Under the alternative cashless exercise option, a holder of a Series B Warrant has the right to receive an aggregate number of shares of common stock equal to the product of (i)